HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TYK MEDICINES-B

2.680

-0.770-22.32%

Volume:7.77M

Turnover:22.76M

Market Cap:1.02B

PE:-2.86

High:3.550

Open:3.550

Low:2.615

Close:3.450

52wk High:22.560

52wk Low:2.615

Shares:380.07M

HK Float Shares:375.46M

Volume Ratio:0.98

T/O Rate:2.07%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.935

ROE:-70.66%

ROA:-28.19%

PB:3.34

PE(LYR):-2.86

PS:8140.94

Loading ...

Overview Company News Filings

TYK MEDICINES-B: Yusheng Wu Acquires Shares, Long Position Rises to 32.59%

TYK MEDICINES-B: Yusheng Wu Acquires Shares, Long Position Rises to 32.57%

TYK Medicines' Chairman Boosts Stake; Shares Down 8%

MT Newswires Live

TYK Medicines-B Chairman, President and CEO Wu Yusheng Plans Share Purchase

Tyk Medicines - Increase in Shareholding by CEO Will not Exceed HK$2 Mln

THOMSON REUTERS

Tyk Medicines - Chairman, CEO DR. Wu Yusheng Purchases Shares of Tyk Medicines on Open Market

THOMSON REUTERS

Insider Sellers Might Regret Selling TYK Medicines Shares at a Lower Price Than Current Market Value

Simply Wall St.

Regulatory Approval Granted to TY-9591, a Novel Targeted Therapy for EGFR-Mutant Lung Cancer With Brain Metastases

Shares of TYK Medicines-B Jump Nearly 15% in Morning Trading as Its Innovative Drug TY-9591 Receives Conditional Market Approval

TYK MEDICINES-B Secures Conditional NMPA Approval for Its Novel EGFR-TKI Therapy

TYK Medicines Says China Regulator Grants Conditional Approval for TY-9591 Lung Cancer Drug

Tyk Medicines - Asandeutertinib Mesylate Tablets (Ty-9591) Obtains Conditional Marketing Approval from Nmpa

THOMSON REUTERS

TYK Medicines Extends Long-Stop Date for 63.22 Million H-Share Placement to 20 September 2026

Bulletin Express

Hong Kong Stock Spotlight | TYK Medicines-B (02410) Climbs Over 6% in Morning Trade as Half-Year Loss Narrows Sharply and TY-9591 Commercialization Ramps Up

TYK Medicines-B Narrows First-Half Loss Significantly as Manufacturing and Commercial Expansion Moves Forward

TYK Medicines outlines 2026 board reshuffle, schedules vote on seven director re-elections

Bulletin Express

TYK Medicines FY26 H1 Comprehensive Loss Narrows 76.4% to RMB 26.88 Million

TYK Medicines Files List of Directors, Board Committee Memberships and Disclosure-Responsible Management

TYK Medicines Non-Executive Director Jiang Mingyu Resigns, Wu Yusheng Named Authorized Representative

TYK Medicines Sets 17 August 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/02410/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"TYK MEDICINES-B","latestPrice":2.68,"timestamp":1789027724000,"preClose":3.45,"halted":0,"volume":7767000,"delay":0,"changeRate":-0.22318840579710145,"floatShares":375457818,"shares":380065818,"eps":-0.9354599918446724,"marketStatus":"Closed","change":-0.77,"latestTime":"09-10 16:08:44","open":3.55,"high":3.55,"low":2.615,"amount":22756187,"amplitude":0.271014,"askPrice":2.68,"askSize":295500,"bidPrice":2.675,"bidSize":7000,"shortable":3,"etf":0,"ttmEps":-0.6565935216508265,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":3.45,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.982993,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":375457818,"roa":"-28.19%","roe":"-70.66%","lyrEps":-0.93546,"volumeRatio":0.982993,"shares":380065818,"dividePrice":0,"high":3.55,"amplitude":0.271014,"preClose":3.45,"low":2.615,"week52Low":2.615,"pbRate":"3.34","psRate":"8140.94","week52High":22.56,"institutionHeld":0,"latestPrice":2.68,"committee":-0.953719,"eps":-0.9354599918446724,"divideRate":0,"volume":7767000,"delay":0,"ttmEps":-0.6565935216508265,"open":3.55,"prevYearClose":13.11,"prevWeekClose":6.205,"prevMonthClose":5.56,"prevQuarterClose":5.73,"fiveDayClose":6.065,"twentyDayClose":6.85,"sixtyDayClose":6.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"date":"2026-03-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-31","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756603800000,"name":null,"time":"","dateTimestamp":1756569600000,"actualEps":null},{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2026-09-09","current":-4.393179,"percent":1,"low":-45.171338,"twenty":-23.850097,"median":-16.983362,"eighty":-11.991643,"high":-5.344387,"avg":-17.864597,"sd":7.240648,"marketCap":1327124672},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-05-02","current":-30.859428,"twenty":-28.772127,"median":-24.368612,"eighty":-19.308976,"marketCap":12738210348},{"date":"2025-05-09","current":-26.222368,"twenty":-28.789228,"median":-24.487968,"eighty":-19.376573,"marketCap":11477368567},{"date":"2025-05-16","current":-19.875071,"twenty":-28.703724,"median":-24.44033,"eighty":-19.45318,"marketCap":8770267095},{"date":"2025-05-23","current":-18.391406,"twenty":-28.460584,"median":-24.320388,"eighty":-19.147078,"marketCap":8139846205},{"date":"2025-05-30","current":-16.767615,"twenty":-28.328721,"median":-24.116277,"eighty":-18.777931,"marketCap":7453799941},{"date":"2025-06-06","current":-19.720458,"twenty":-27.077703,"median":-23.93026,"eighty":-18.847277,"marketCap":8788808886},{"date":"2025-06-13","current":-16.18601,"twenty":-26.697665,"median":-23.850097,"eighty":-18.709822,"marketCap":7216465018},{"date":"2025-06-20","current":-14.05098,"twenty":-26.664525,"median":-23.778892,"eighty":-18.426653,"marketCap":6252291891},{"date":"2025-06-27","current":-16.3221,"twenty":-26.630078,"median":-23.66211,"eighty":-18.32609,"marketCap":7283215465},{"date":"2025-07-04","current":-17.493079,"twenty":-26.41078,"median":-23.623818,"eighty":-18.194509,"marketCap":7806093968},{"date":"2025-07-11","current":-16.487526,"twenty":-26.267076,"median":-23.430941,"eighty":-17.964216,"marketCap":7349965912},{"date":"2025-07-18","current":-15.867745,"twenty":-26.226866,"median":-23.321155,"eighty":-17.866761,"marketCap":7068130691},{"date":"2025-07-25","current":-16.407488,"twenty":-26.143659,"median":-23.070409,"eighty":-17.335488,"marketCap":7335132480},{"date":"2025-08-01","current":-14.539711,"twenty":-26.072617,"median":-22.868028,"eighty":-17.325642,"marketCap":6459959949},{"date":"2025-08-08","current":-15.316665,"twenty":-25.987382,"median":-22.563641,"eighty":-17.04089,"marketCap":6822181433},{"date":"2025-08-15","current":-17.450454,"twenty":-25.968574,"median":-22.406203,"eighty":-16.915178,"marketCap":7760944003},{"date":"2025-08-22","current":-13.484776,"twenty":-25.95357,"median":-22.354126,"eighty":-16.718364,"marketCap":5978435317},{"date":"2025-08-29","current":-12.516323,"twenty":-25.925655,"median":-21.46252,"eighty":-16.486483,"marketCap":5575565550},{"date":"2025-09-05","current":-19.23268,"twenty":-25.919389,"median":-21.226743,"eighty":-16.486483,"marketCap":5883418862},{"date":"2025-09-12","current":-18.156363,"twenty":-25.850806,"median":-20.678772,"eighty":-16.541494,"marketCap":5564163575},{"date":"2025-09-19","current":-18.839434,"twenty":-25.807696,"median":-20.500943,"eighty":-16.56352,"marketCap":5769399117},{"date":"2025-09-26","current":-19.348832,"twenty":-25.743581,"median":-20.268382,"eighty":-16.654406,"marketCap":5910023469},{"date":"2025-10-03","current":-22.468168,"twenty":-25.650075,"median":-20.314843,"eighty":-16.707921,"marketCap":6879191305},{"date":"2025-10-10","current":-19.927643,"twenty":-25.596841,"median":-20.323115,"eighty":-16.732368,"marketCap":6092455062},{"date":"2025-10-17","current":-19.134493,"twenty":-25.519561,"median":-20.155539,"eighty":-16.749672,"marketCap":5845412280},{"date":"2025-10-24","current":-17.635142,"twenty":-25.404318,"median":-19.980008,"eighty":-16.781291,"marketCap":5389333299},{"date":"2025-10-31","current":-19.024541,"twenty":-25.400784,"median":-19.927643,"eighty":-16.830147,"marketCap":5822608331},{"date":"2025-11-07","current":-17.694439,"twenty":-25.37593,"median":-19.869193,"eighty":-16.945559,"marketCap":5412137248},{"date":"2025-11-14","current":-17.099248,"twenty":-25.321084,"median":-19.741813,"eighty":-16.951188,"marketCap":5244908288},{"date":"2025-11-21","current":-15.19815,"twenty":-25.311733,"median":-19.694587,"eighty":-16.919035,"marketCap":4659606928},{"date":"2025-11-28","current":-16.711808,"twenty":-25.293455,"median":-19.641679,"eighty":-16.730587,"marketCap":5142290517},{"date":"2025-12-05","current":-17.262657,"twenty":-25.275139,"median":-19.635782,"eighty":-16.587841,"marketCap":5320921452},{"date":"2025-12-12","current":-16.160016,"twenty":-25.213434,"median":-19.544821,"eighty":-16.497144,"marketCap":4990264190},{"date":"2025-12-19","current":-16.355316,"twenty":-25.19336,"median":-19.414876,"eighty":-16.454475,"marketCap":5062476695},{"date":"2025-12-24","current":-15.692499,"twenty":-25.154877,"median":-19.348832,"eighty":-16.406101,"marketCap":4872443786},{"date":"2026-01-02","current":-15.765099,"twenty":-25.10227,"median":-19.292077,"eighty":-16.35327,"marketCap":4914251026},{"date":"2026-01-09","current":-17.392186,"twenty":-25.070347,"median":-19.235279,"eighty":-16.345574,"marketCap":5434941197},{"date":"2026-01-16","current":-16.438751,"twenty":-25.06473,"median":-19.137216,"eighty":-16.35327,"marketCap":5153692492},{"date":"2026-01-23","current":-15.75073,"twenty":-25.023112,"median":-19.120814,"eighty":-16.314941,"marketCap":4933254317},{"date":"2026-01-30","current":-15.280433,"twenty":-24.971672,"median":-19.022068,"eighty":-16.22453,"marketCap":4807832597},{"date":"2026-02-06","current":-15.542994,"twenty":-24.952303,"median":-18.937078,"eighty":-16.152588,"marketCap":4902849052},{"date":"2026-02-13","current":-15.334427,"twenty":-24.923448,"median":-18.860882,"eighty":-16.099082,"marketCap":4864842470},{"date":"2026-02-20","current":-15.572498,"twenty":-24.905533,"median":-18.847277,"eighty":-16.071561,"marketCap":4933254317},{"date":"2026-02-27","current":-14.952615,"twenty":-24.827654,"median":-18.801141,"eighty":-15.988536,"marketCap":4788829306},{"date":"2026-03-06","current":-13.279596,"twenty":-24.77147,"median":-18.709822,"eighty":-15.892604,"marketCap":4218730579},{"date":"2026-03-13","current":-12.861452,"twenty":-24.760877,"median":-18.616931,"eighty":-15.828013,"marketCap":4104710834},{"date":"2026-03-20","current":-12.157235,"twenty":-24.758022,"median":-18.440891,"eighty":-15.765099,"marketCap":3865269369},{"date":"2026-03-27","current":-12.164275,"twenty":-24.758022,"median":-18.409208,"eighty":-15.692499,"marketCap":3857668052},{"date":"2026-04-02","current":-12.25818,"twenty":-24.73228,"median":-18.399621,"eighty":-15.606124,"marketCap":4180723998},{"date":"2026-04-10","current":-12.412577,"twenty":-24.72344,"median":-18.391406,"eighty":-15.554796,"marketCap":4266032641},{"date":"2026-04-17","current":-12.351427,"twenty":-24.717087,"median":-18.309793,"eighty":-15.461655,"marketCap":4246798950},{"date":"2026-04-24","current":-11.422185,"twenty":-24.709149,"median":-18.216326,"eighty":-15.337994,"marketCap":3927519681},{"date":"2026-04-30","current":-11.117278,"twenty":-24.702871,"median":-18.174743,"eighty":-15.304685,"marketCap":3823657750},{"date":"2026-05-08","current":-10.777891,"twenty":-24.684547,"median":-18.056929,"eighty":-15.189837,"marketCap":3719795820},{"date":"2026-05-15","current":-9.293361,"twenty":-24.617578,"median":-17.965815,"eighty":-15.119492,"marketCap":3215873118},{"date":"2026-05-22","current":-8.991533,"twenty":-24.605712,"median":-17.939574,"eighty":-15.043492,"marketCap":3104317711},{"date":"2026-05-29","current":-10.14843,"twenty":-24.599189,"median":-17.918048,"eighty":-14.961326,"marketCap":3515918696},{"date":"2026-06-05","current":-8.237808,"twenty":-24.571342,"median":-17.89208,"eighty":-14.895383,"marketCap":2858126467},{"date":"2026-06-12","current":-7.644268,"twenty":-24.535606,"median":-17.732128,"eighty":-14.684931,"marketCap":2650402606},{"date":"2026-06-18","current":-6.884404,"twenty":-24.459385,"median":-17.688347,"eighty":-14.384241,"marketCap":2392671147},{"date":"2026-06-26","current":-6.195227,"twenty":-24.397853,"median":-17.672452,"eighty":-13.470121,"marketCap":2142633166},{"date":"2026-07-03","current":-7.179757,"twenty":-24.364887,"median":-17.499062,"eighty":-13.369605,"marketCap":2484992864},{"date":"2026-07-10","current":-8.078806,"twenty":-24.314468,"median":-17.476751,"eighty":-13.262753,"marketCap":2792731918},{"date":"2026-07-17","current":-8.127776,"twenty":-24.232724,"median":-17.419476,"eighty":-13.079412,"marketCap":2819659085},{"date":"2026-07-24","current":-7.604914,"twenty":-24.150839,"median":-17.377721,"eighty":-12.93356,"marketCap":2638862391},{"date":"2026-07-31","current":-7.53517,"twenty":-24.119743,"median":-17.333807,"eighty":-12.87079,"marketCap":2619628700},{"date":"2026-08-07","current":-7.625479,"twenty":-24.07756,"median":-17.320685,"eighty":-12.528428,"marketCap":2656172713},{"date":"2026-08-14","current":-7.417307,"twenty":-24.00283,"median":-17.276309,"eighty":-12.375887,"marketCap":2586931426},{"date":"2026-08-21","current":-10.34776,"twenty":-23.939778,"median":-17.197085,"eighty":-12.303816,"marketCap":2563850996},{"date":"2026-08-28","current":-9.732294,"twenty":-23.880566,"median":-17.053511,"eighty":-12.176647,"marketCap":2411904838},{"date":"2026-09-04","current":-9.627537,"twenty":-23.866484,"median":-17.033052,"eighty":-12.068009,"marketCap":2386901040},{"date":"2026-09-09","current":-5.344387,"twenty":-23.850097,"median":-16.983362,"eighty":-11.991643,"marketCap":1327124672}],"updateTime":1789024785025},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1159870558","title":"TYK MEDICINES-B: Yusheng Wu Acquires Shares, Long Position Rises to 32.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159870558","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159870558?lang=en_us&edition=fundamental","pubTime":"2026-09-10 17:45","pubTimestamp":1789033525,"startTime":"0","endTime":"0","summary":"Yusheng Wu bought 60,000 shares of TYK MEDICINES-B stock at an average of HKD 3.4513 per share on September 9, 2026, involving about HKD 207,078.Prior to the acquisition, Yusheng Wu's long position...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a44b570a4bc942c79569e09a943adc8c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117392070","title":"TYK MEDICINES-B: Yusheng Wu Acquires Shares, Long Position Rises to 32.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117392070","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117392070?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:33","pubTimestamp":1788946419,"startTime":"0","endTime":"0","summary":"On September 8, 2026, Yusheng Wu bought 350,000 shares of TYK MEDICINES-B stock at an average of HKD 3.4626 per share, involving about HKD 1.21 million.Prior to the acquisition, Yusheng Wu's long...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a44b570a4bc942c79569e09a943adc8c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666018103","title":"TYK Medicines' Chairman Boosts Stake; Shares Down 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666018103","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666018103?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:58","pubTimestamp":1788922711,"startTime":"0","endTime":"0","summary":"TYK Medicines  said Chairman and Chief Executive Officer Wu Yusheng has recently purchased company shares on the open market and may make further purchases depending on market conditions.The total increase in his shareholding is currently expected not to exceed HK$2 million, according to a Hong Kong bourse filing.Wu will fund the purchases with his own funds and has undertaken to voluntarily lock up the shares acquired over the next month for six months from their respective purchase dates.Shares of the firm were down nearly 10% in Wednesday morning trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02410","MDCO","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136667600","title":"TYK Medicines-B Chairman, President and CEO Wu Yusheng Plans Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1136667600","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136667600?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:26","pubTimestamp":1788873985,"startTime":"0","endTime":"0","summary":"TYK Medicines-B (02410) has announced that its Chairman, Executive Director and President, Dr. Wu Yusheng, has informed the company of his recent share purchases in the open market. Dr. Wu may...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","02410","BK1161","BK1574","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373008","title":"Tyk Medicines - Increase in Shareholding by CEO Will not Exceed HK$2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373008","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665373008?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:20","pubTimestamp":1788873615,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN4500SM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373005","title":"Tyk Medicines - Chairman, CEO DR. Wu Yusheng Purchases Shares of Tyk Medicines on Open Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665373005?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:20","pubTimestamp":1788873615,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN4500SM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882893","title":"Insider Sellers Might Regret Selling TYK Medicines Shares at a Lower Price Than Current Market Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882893","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664882893?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:51","pubTimestamp":1788216672,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc's (HKG:2410) value has fallen 12% in the last week, but insiders who sold CN¥4.0m worth of stock...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2410/tyk-medicines-shares/news/insider-sellers-might-regret-selling-tyk-medicines-shares-at","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2410/tyk-medicines-shares/news/insider-sellers-might-regret-selling-tyk-medicines-shares-at","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02410","MDCO","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160195838","title":"Regulatory Approval Granted to TY-9591, a Novel Targeted Therapy for EGFR-Mutant Lung Cancer With Brain Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=1160195838","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160195838?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:32","pubTimestamp":1787884340,"startTime":"0","endTime":"0","summary":"On August 27, 2026, Hong Kong-listed innovative drug developer TYK Medicines-B (02410) announced that its independently developed Class 1 new drug, Dutersatinib mesylate tablets (TY-9591), received...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK1161","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156832241","title":"Shares of TYK Medicines-B Jump Nearly 15% in Morning Trading as Its Innovative Drug TY-9591 Receives Conditional Market Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1156832241","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156832241?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:41","pubTimestamp":1787881292,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) saw its shares surge nearly 15% in early trading, with the stock climbing 14.99% to HK$7.825 at the time of writing, on a turnover of HK$2.758 million.On the evening of August...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161","06978","BK1574","IPOS","LNGR","MEDX","IBBQ","159992","159938","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191561333","title":"TYK MEDICINES-B Secures Conditional NMPA Approval for Its Novel EGFR-TKI Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1191561333","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191561333?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:26","pubTimestamp":1787837163,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) has announced that its independently developed next-generation EGFR-TKI innovative drug, Duxenaitinib Mesylate Tablets (TY-9591), has received conditional marketing approval...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK1574","BK1515","159938","09939","BK1161","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662088664","title":"TYK Medicines Says China Regulator Grants Conditional Approval for TY-9591 Lung Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2662088664","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662088664?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:17","pubTimestamp":1787836653,"startTime":"0","endTime":"0","summary":"TYK Medicines says China regulator grants conditional approval for TY-9591 lung cancer drugChina’s NMPA granted conditional marketing clearance for TY-9591, a next-generation EGFR-TKI, for first-line ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL7DjG9F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662088571","title":"Tyk Medicines - Asandeutertinib Mesylate Tablets (Ty-9591) Obtains Conditional Marketing Approval from Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2662088571","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662088571?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:16","pubTimestamp":1787836581,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1H8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162059231","title":"TYK Medicines Extends Long-Stop Date for 63.22 Million H-Share Placement to 20 September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1162059231","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162059231?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:28","pubTimestamp":1787225297,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. has pushed back the long-stop date for completing its planned issuance of 63.22 million H shares under general mandate. According to an announcement dated 20 August 2026, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161497517","title":"Hong Kong Stock Spotlight | TYK Medicines-B (02410) Climbs Over 6% in Morning Trade as Half-Year Loss Narrows Sharply and TY-9591 Commercialization Ramps Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1161497517","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161497517?lang=en_us&edition=fundamental","pubTime":"2026-08-18 11:11","pubTimestamp":1787022675,"startTime":"0","endTime":"0","summary":"TYK Medicines-B (02410) saw its share price rally more than 6% during the morning session, last trading 5.63% higher at HK$7.13 with turnover reaching HK$16.15 million.The company's interim results...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TY","BK4588","VXUS","KCAI","159938","09939","BK1515","02410","BK1161","BK1574","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181695401","title":"TYK Medicines-B Narrows First-Half Loss Significantly as Manufacturing and Commercial Expansion Moves Forward","url":"https://stock-news.laohu8.com/highlight/detail?id=1181695401","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181695401?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:49","pubTimestamp":1786970980,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) has reported its interim results for the 2026 fiscal year, revealing a substantial improvement in its financial performance. Research and development costs reached RMB 94.943...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","09939","BK1515","02410","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158885908","title":"TYK Medicines outlines 2026 board reshuffle, schedules vote on seven director re-elections","url":"https://stock-news.laohu8.com/highlight/detail?id=1158885908","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158885908?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:44","pubTimestamp":1786970690,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. has disclosed a forthcoming leadership transition and a planned board refresh. Key changes   • Non-executive director (NED) Dr. Jiang Mingyu will step down on 17 August 2026 to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660848081","title":"TYK Medicines FY26 H1 Comprehensive Loss Narrows 76.4% to RMB 26.88 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660848081","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660848081?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:34","pubTimestamp":1786970047,"startTime":"0","endTime":"0","summary":"TYK Medicines FY26 H1 comprehensive loss narrows 76.4% to RMB 26.88 millionTYK Medicines posted a total comprehensive loss of RMB 26.88 million, narrowing 76.4% from the year-earlier period.Loss attri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL9X5R5W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660876314","title":"TYK Medicines Files List of Directors, Board Committee Memberships and Disclosure-Responsible Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2660876314","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660876314?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:15","pubTimestamp":1786968931,"startTime":"0","endTime":"0","summary":"TYK Medicines files list of directors, board committee memberships and disclosure-responsible managementTYK Medicines named Dr. WU Yusheng as executive director.Non-executive directors: Dr. LI Jun, Dr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDLyXhG9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487885","title":"TYK Medicines Non-Executive Director Jiang Mingyu Resigns, Wu Yusheng Named Authorized Representative","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487885","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487885?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:05","pubTimestamp":1786968349,"startTime":"0","endTime":"0","summary":"TYK Medicines non-executive director Jiang Mingyu resigns, Wu Yusheng named authorized representativeTYK Medicines announced the resignation of non-executive director Jiang Mingyu, effective Aug. 17, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL6XfymN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126200437","title":"TYK Medicines Sets 17 August 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1126200437","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126200437?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:27","pubTimestamp":1785922076,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc will convene its board of directors on 17 August 2026 to review and approve the consolidated interim results for the six months ended 30 June 2026. The agenda also includes...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":63,"code":"91000000","status":"200"}]}}